AKORN (NASDAQ:AKRX)
1.61
+0.01 (0.63%)
| AKORN (NASDAQ:AKRX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.60 | 52 Week High | $2.99 | ||
| Open | $1.58 | 52 Week Low | $0.73 | ||
| Day High | $1.64 | P/E | N/A | ||
| Day Low | $1.58 | EPS | $-0.28 | ||
| Volume | 207,544 | ||||
| More AKRX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| HOO | 2 | DDSS | 2 |
| GILT | 2 | PAY | 2 |
| OPTN | 1 | ARM | 1 |
| EAR | 1 | HOGS | 1 |
| ORBT | 1 | TIER | 1 |
| RVSB | 1 | ALCO | 1 |
Entities who have mentioned AKRX
- SAC Capital | View Related Stories »
- Steven A. Cohen | View Related Stories »
- Trading Radar | View Related Stories »
- Soleil Securities | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- S3 | View Related Stories »
- Credit Suisse | View Related Stories »
- Citi | View Related Stories »
- GLG Partners | View Related Stories »
- Dividend | View Related Stories »
- Morgan Joseph | View Related Stories »
- Morgan Keegan & Company | View Related Stories »
- UBS | View Related Stories »
- The Children's Investment Fund (TCI) | View Related Stories »
View All ReportsStreetInsider.com Reports on AKRX
- Akorn (AKRX) Posts Q3 Loss of $0.06, Beats By 2c
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Akorn (AKRX) Files Shelf Offering of Up To 13.3M Shares
- Akorn (AKRX) Reports Wider Q2 Loss
- Trading Radar for 8/10: DISH (DISH), Echostar (SATS), SYSCO (SYY), Fluor (FLR), Rackspace (RAX), priceline.com (PCLN) Report
View All Press ReleasesCompany Press Releases on AKRX
- Akorn Reports Third Quarter 2009 Financial Results; Launches Two New Products: Ketorolac Tromethamine Ophthalmic and Hydralazine HCL
- Akorn, Inc. Announces Third Quarter 2009 Earnings Release and Conference Call Information
StreetInsider Reports on AKRX by Category
View All BlogsBlogs on AKRX
- Pequot's 13G Filing Details Positions Unwound
- Pequot Capital Sells the Bulk of Its Akorn Stake
- Pequot Capital Closes: Expect Downward Pressure on Top Holdings
- Investing in India's Generic Drug Market
- Akorn, Inc. Q3 2008 Earnings Call Transcript
Comments on AKRX
No comments are currently available.
